| Sumario: | The article focuses on the underrepresentation of women in biomedical research and clinical trials, highlighting the need for policy changes to promote inclusive, sex-informed research. It discusses how persistent biases lead to gaps in understanding health issues that uniquely affect women, resulting in inadequate medical solutions and increased health risks. The article emphasizes the importance of initiatives like the National Institutes of Health's Office of Research on Women's Health and the Advanced Research Projects Agency for Health in addressing these disparities. Additionally, it explores the emerging FemTech industry, which aims to improve women's health technologies, while noting the regulatory challenges it faces. Overall, the article advocates for collaborative efforts among policymakers, researchers, and industry leaders to enhance health outcomes for women.
|
|---|